ScholarIQanswers from OpenAlex

Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma

PaperCitations, authors & open-access status

Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma have?

ScholarIQcitation count

Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma has 2 citations in the OpenAlex counts ScholarIQ stores.

When was Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma published?

ScholarIQyear

Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma has 2023 year in the ScholarIQ index.

What is the open-access status of Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma?

ScholarIQoa status

Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma has green oa status in the ScholarIQ index.

What is the DOI of Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma?

ScholarIQdoi

The DOI for Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma is on the source record.

What is the OpenAlex record for Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma?

ScholarIQopenalex

The OpenAlex for Malignant Pseudothyroiditis after COVID-19 Infection Revealing a Poor-Cellular Variant of a Thyroid Anaplastic Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial